NORTH

JOBLO MEDIA founder joins local Montréal pinball company NORTH STAR COIN MACHINE CO. to fund expansion

Retrieved on: 
Monday, October 30, 2023

MONTREAL, Oct. 30, 2023 (GLOBE NEWSWIRE) -- NORTH STAR COIN MACHINE CO. closes new funding round from Montréal internet entrepreneur Berge Garabedian, CEO and founder of the 25-year-old popular internet movie destination JoBlo.com as well as its massive YouTube network.

Key Points: 
  • MONTREAL, Oct. 30, 2023 (GLOBE NEWSWIRE) -- NORTH STAR COIN MACHINE CO. closes new funding round from Montréal internet entrepreneur Berge Garabedian, CEO and founder of the 25-year-old popular internet movie destination JoBlo.com as well as its massive YouTube network.
  • NORTH STAR COIN MACHINE CO. brings a unique, modern take on the Amusement operation business, bringing digital savvy, high brand values and high touch customer service to the new burgeoning era of arcade amusements.
  • People want to get away and just let loose, enjoy the day-to-day and that’s where a company like North Star comes in.
  • North Star Coin Machine Co.: [email protected]

Ellsworth's Heating & Cooling Announces Its Christmas in July Winners

Retrieved on: 
Thursday, November 2, 2023

NORTH FORT MYERS, Fla., Nov. 2, 2023 /PRNewswire/ -- Ellsworth's Heating & Cooling, a trusted name in the HVAC industry for over half a century, is thrilled to announce the winners of their annual "Christmas in July" giveaway. This year, three lucky residents from North Fort Myers, Dan & Nancy Childers, James Mirchko, and Regina Olanoff, are the proud recipients of brand-new air-conditioning units and installations. This heartwarming tradition, in collaboration with the company's manufacturers and the North Florida Myers Coalition, exemplifies its commitment to the community and its dedication to providing quality HVAC solutions.

Key Points: 
  • Ellsworth's Heating & Cooling has announced its Christmas in July giveaway winners, Dan & Nancy Childers, James Mirchko, and Regina Olanoff, in a heartwarming tradition that reflects their deep commitment to the local community.
  • NORTH FORT MYERS, Fla., Nov. 2, 2023 /PRNewswire/ -- Ellsworth's Heating & Cooling, a trusted name in the HVAC industry for over half a century, is thrilled to announce the winners of their annual "Christmas in July" giveaway.
  • Ellsworth's Heating & Cooling has been serving the Lee County region with unmatched dedication and excellence since its inception.
  • Whether you need cooling, heating, Cape Coral AC repair , air quality improvement, or regular maintenance, Ellsworth's Heating & Cooling experienced team has you covered.

PDHI Enters into Partnership with Zipari: PDHI and Zipari Announce Strategic Partnership to Enhance Member Engagement Solutions

Retrieved on: 
Tuesday, October 31, 2023

NORTH BRUNSWICK, N.J., Oct. 31, 2023 /PRNewswire-PRWeb/ -- Protocol-Driven Healthcare Inc. (PDHI), a leading software provider supporting health plan, point of care, and corporate wellness health initiatives, is thrilled to announce its strategic partnership with Zapari, the market leader in healthcare consumer experience technology for health plans and TPAs in the U.S. Together, they are transforming the way members engage with healthcare services by integrating PDHI's ConXus Platform into Zipari's CX Platform.

Key Points: 
  • PDHI and Zipari's strategic partnership is set to enhance member engagement solutions by integrating PDHI's ConXus Platform into Zipari's CX Platform.
  • Both companies aim to personalize member experiences, influence behaviors to improve outcomes and improve population health management.
  • "This partnership offers health plans and TPA an integrated solution that enhances member engagement, encourages healthy behaviors, and identifies at-risk members," said Jennifer Jolley, President & CEO of PDHI.
  • "This partnership offers health plans and TPA an integrated solution that enhances member engagement, encourages healthy behaviors, and identifies at-risk members," said Jennifer Jolley, President & CEO of PDHI.

Even After A Marriage Falls Apart, God Is There To Comfort His Children

Retrieved on: 
Thursday, October 26, 2023

NORTH PORT, Fla., Oct. 26, 2023 /PRNewswire-PRWeb/ -- Author David Lee Druckenmiller shares how his Champion rescued him from a crumbled marriage in Memories of Loving You: Our Forgiven Love ($22.49, paperback, 9781662888090; $9.99, e-book, 9781662888106).

Key Points: 
  • The devil showed himself to be an evil, narcissistic predator, but God also showed Himself to be faithful and gracious.
  • He was Commissioned as an Officer and served 22 years as a Chaplain in the United States Army.
  • Xulon Press, a division of Salem Media Group, is the world's largest Christian self-publisher, with more than 20,000 titles published to date.
  • CH (LTC-R) David Lee Druckenmiller, Salem Author Services, 941-368-8410, [email protected]
    View original content to download multimedia: https://www.prweb.com/releases/even-after-a-marriage-falls-apart-god-is-...

Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award

Retrieved on: 
Monday, October 23, 2023

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a global clinical-stage biotechnology company focused on innovative oncology drugs, and Nucleai, a pathology-based AI-powered biomarker discovery and diagnostics company, is pleased to announce today the receipt of the ESMO 2023 Best Poster Award for the Sunday, October 22, 2023 poster session with the presentation of the study “Utilizing H&E Images and Digital Pathology to Predict Response to Buparlisib in SCCHN”.

Key Points: 
  • SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a global clinical-stage biotechnology company focused on innovative oncology drugs, and Nucleai, a pathology-based AI-powered biomarker discovery and diagnostics company, is pleased to announce today the receipt of the ESMO 2023 Best Poster Award for the Sunday, October 22, 2023 poster session with the presentation of the study “Utilizing H&E Images and Digital Pathology to Predict Response to Buparlisib in SCCHN”.
  • We are extremely pleased the study was recognized for its quality and success,” said Dr. Lars Birgerson, President & CMO of Adlai Nortye.
  • The poster, #869P, was presented at the Head and Neck Cancers poster session on Sunday, October 22, 2023.
  • The Best Poster Award was given at the conclusion of the Sunday Poster Session.

Jonathan Milner Issues Statement Responding to the Glass Lewis Report

Retrieved on: 
Monday, October 23, 2023

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

Retrieved on: 
Monday, October 16, 2023

NORTH BRUNSWICK, N.J., Oct. 16, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, is pleased to announce a second partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. This partnership comes with the award of a $20 million contract from BARDA’s Division of Research, Innovation, and Ventures (DRIVe), to advance gelsolin, a master regulator of the innate immune system, for the treatment of Acute Respiratory Distress Syndrome (ARDS). This significant injection of funding accelerates BioAegis’ ARDS program and the execution of its strategy to transform the treatment of inflammatory diseases.

Key Points: 
  • This partnership comes with the award of a $20 million contract from BARDA’s Division of Research, Innovation, and Ventures (DRIVe), to advance gelsolin, a master regulator of the innate immune system, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
  • This significant injection of funding accelerates BioAegis’ ARDS program and the execution of its strategy to transform the treatment of inflammatory diseases.
  • Acute Respiratory Distress Syndrome (ARDS) is a condition that can develop as a severe complication of pneumonia, sepsis, or trauma resulting in life-threatening lung injury with fluid leakage into the lungs.
  • Breathing becomes difficult and patients require oxygen, mechanical ventilation and extensive critical care resources, placing a significant burden on the healthcare system.

Jonathan Milner Issues Statement Responding to ISS Report

Retrieved on: 
Monday, October 16, 2023

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company

Retrieved on: 
Monday, October 16, 2023

DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.

Key Points: 
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER IS NOT RESPONSIBLE TO ANY PERSON FOR PROVIDING ADVICE IN RELATION TO THE SUBJECT MATTER OF THIS DOCUMENT.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Retrieved on: 
Tuesday, October 10, 2023

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.